کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2112842 | 1084426 | 2013 | 8 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: The natural product honokiol inhibits calcineurin inhibitor-induced and Ras-mediated tumor promoting pathways The natural product honokiol inhibits calcineurin inhibitor-induced and Ras-mediated tumor promoting pathways](/preview/png/2112842.png)
• Calcineurin inhibitors (CNIs) are very good agents to prevent allograft rejection.
• However, they can induce tumor-promoting pathways through activation of ras.
• The natural product honokiol down-regulated CNI-induced and Ras-mediated pathways.
• It inhibited CNI-induced survival of renal cancer cells.
• Thus, honokiol treatment may prevent CNI-induced tumor growth in transplant patients.
Although calcineurin inhibitors (CNIs) are very useful in preventing allograft rejection, they can mediate a rapid progression of post-transplantation malignancies. The CNI cyclosporine A (CsA) can promote renal tumor growth through activation of the proto-oncogene ras and over-expression of the angiogenic cytokine VEGF; the ras activation also induces over-expression of the cytoprotective enzyme HO-1, which promotes survival of renal cancer cells. Here, we show that the natural product honokiol significantly inhibited CsA-induced and Ras-mediated survival of renal cancer cells through the down-regulations of VEGF and HO-1. Thus, honokiol treatment may help to prevent tumor-promoting effects of CsA in transplant patients.
Journal: Cancer Letters - Volume 338, Issue 2, 28 September 2013, Pages 292–299